估计范围内时间(eTIR)毛细血管血糖与HbA1c在糖尿病控制与并发症试验中与微血管并发症进展的关联
基于糖尿病控制与并发症试验(DCCT)的毛细血管血糖谱估算范围内时间(eTIR),在未校正和校正HbA1c及基线协变量后分析其与糖尿病视网膜病变和微量白蛋白尿的关联。校正HbA1c后,eTIR与视网膜病变仅呈边缘显著关联(HR 1.12/每降低10% eTIR,95%CI 1.0–1.26,P=0.042);HbA1c在校正分析中与两项结局均显著关联。作者认为eTIR与并发症的关联在很大程度上可由其与HbA1c的相关性解释,HbA1c仍是1型糖尿病并发症临床研究的首选结局。
要点
- 校正HbA1c后,eTIR与视网膜病变仅边缘显著关联(HR 1.12/每降低10% eTIR)。
- 6项校正分析中有5项显示HbA1c与两项结局显著关联(HR≥1.19/每升高0.5% HbA1c,P≤0.0002)。
- 作者认为eTIR与并发症的关联在很大程度上可由其与HbA1c的相关性解释,HbA1c仍是首选结局。
核心结论
- eTIR与并发症的关联在很大程度上可由其与HbA1c的相关性解释。
- HbA1c而非eTIR或持续葡萄糖监测TIR,仍是1型糖尿病并发症临床研究的首选结局。
研究设计与样本
- 研究利用糖尿病控制与并发症试验(DCCT)的血糖谱(餐前、餐后及睡前)估算eTIR,分析其与糖尿病视网膜病变和微量白蛋白尿的关联,分别在不校正和校正HbA1c及基线协变量后进行评估。
主要发现
- 校正HbA1c及协变量后,eTIR与视网膜病变在全队列中呈边缘显著关联(每降低10% eTIR的HR 1.12,95%CI 1.0–1.26,P=0.042)。
- 校正分析中,HbA1c与两项结局均显著关联(每升高0.5% HbA1c的HR≥1.19,P≤0.0002),见于6项校正分析中的5项。
关键数值与推荐
- eTIR与视网膜病变:校正HbA1c及协变量后,每降低10% eTIR的HR 1.12(95%CI 1.0–1.26,P=0.042)。
- HbA1c与两项结局:每升高0.5% HbA1c的HR≥1.19(P≤0.0002),见于6项校正分析中的5项。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Estimated time in range (eTIR) obtained from DCCT glucose profiles (pre- and postprandial and bedtime) was recently reported to be associated with microvascular outcomes and was recommended as a clinical trial outcome, but without consideration of HbA1c. RESEARCH DESIGN AND METHODS: The associations of eTIR with diabetic retinopathy and microalbuminuria were assessed without and with adjustment for HbA1c and baseline covariates. RESULTS: Adjusted for HbA1c and covariates, eTIR was marginally significantly associated with retinopathy in the full cohort (hazard ratio [HR] 1.12 per 10% lower eTIR [95% CI 1.0, 1.26], P = 0.042). Conversely, HbA1c was significantly associated with both outcomes (HR ≥1.19 per 0.5% higher HbA1c, P ≤ 0.0002) in five of six adjusted analyses. CONCLUSIONS: The association of eTIR with complications is largely explained by its correlation with HbA1c. HbA1c, not eTIR or continuous glucose monitoring TIR, remains the preferred outcome in clinical studies of type 1 diabetes complications.
引用
- Lachin JM, Bebu I, Gao X, et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care. 2022. PMID: 35972222. doi:10.2337/dc21-2298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。